Pengcheng Li Selected Research

X-Linked Inhibitor of Apoptosis Protein

9/2018	X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.
5/2018	Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pengcheng Li Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 05/2010
14	Bites and Stings (Sting) 11/2023 - 06/2014
12	Infections 05/2024 - 05/2011
10	Inflammation (Inflammations) 01/2024 - 10/2019
9	Osteosarcoma (Osteogenic Sarcoma) 04/2022 - 01/2016
8	Carcinogenesis 04/2024 - 01/2016
7	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2015
6	Wounds and Injuries (Trauma) 11/2023 - 10/2009
5	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2014
5	Adenocarcinoma of Lung 09/2020 - 02/2015
4	Body Weight (Weight, Body) 05/2024 - 12/2014
4	Dermatitis 01/2024 - 10/2019
4	Lung Neoplasms (Lung Cancer) 11/2021 - 02/2015
4	Hemolysis 03/2021 - 07/2011
3	Obesity 05/2024 - 01/2017
3	Hemorrhage 04/2024 - 12/2014
3	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 01/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2009
3	Starvation 10/2023 - 12/2018
3	Hypertension (High Blood Pressure) 10/2023 - 01/2017
3	Fibrosis (Cirrhosis) 10/2023 - 01/2020
3	Pain (Aches) 07/2023 - 09/2013
3	Virus Diseases (Viral Diseases) 04/2023 - 01/2019
3	Hypothyroidism 05/2021 - 02/2016
3	Carcinoma (Carcinomatosis) 02/2015 - 06/2012
2	Edema (Dropsy) 04/2024 - 09/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2024 - 01/2014
2	Hyperglycemia 01/2024 - 11/2008
2	Autolysis 01/2024 - 01/2021
2	Sepsis (Septicemia) 01/2024 - 01/2019
2	Lung Injury 01/2024 - 01/2017
2	Myotoxicity 12/2023 - 07/2022
2	Stomach Neoplasms (Stomach Cancer) 10/2022 - 04/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2021
2	Uterine Cervical Dysplasia 12/2021 - 12/2020
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2018
2	Newcastle Disease 02/2020 - 01/2016
2	Dyspnea (Shortness of Breath) 12/2014 - 09/2013
2	Acute Kidney Injury (Acute Renal Failure) 12/2014 - 04/2014

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2009
17	VenomsIBA 01/2024 - 09/2013
10	Metalloproteases (Metalloproteinases)IBA 01/2024 - 06/2014
8	Long Noncoding RNAIBA 01/2022 - 08/2017
7	Small Interfering RNA (siRNA)IBA 09/2023 - 01/2006
7	ChitosanIBA 08/2021 - 04/2014
6	Peptides (Polypeptides)IBA 04/2023 - 09/2014
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2017
5	EnzymesIBA 05/2024 - 07/2010
5	AntioxidantsIBA 01/2024 - 09/2014
5	Cnidarian VenomsIBA 12/2023 - 09/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2015
5	MicroRNAs (MicroRNA)IBA 10/2018 - 01/2016
4	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2016
4	CytokinesIBA 07/2022 - 01/2009
4	Phosphotransferases (Kinase)IBA 01/2022 - 02/2014
4	Polysaccharides (Glycans)IBA 01/2022 - 12/2015
4	Messenger RNA (mRNA)IBA 11/2021 - 01/2013
3	Therapeutic UsesIBA 01/2024 - 01/2014
3	SaltsIBA 01/2024 - 01/2016
3	LigandsIBA 01/2024 - 05/2018
3	Oxygen (Dioxygen)IBA 12/2023 - 06/2010
3	Amino Acids FDA Link 10/2023 - 02/2016
3	Antivenins (Antivenoms)IBA 03/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 11/2020 - 01/2018
3	Docetaxel (Taxotere)FDA Link 04/2019 - 08/2017
3	AcidsIBA 04/2019 - 11/2015
2	AnticoagulantsIBA 04/2024 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 11/2015
2	PlatinumIBA 04/2024 - 08/2022
2	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 01/2021
2	CholesterolIBA 01/2024 - 01/2017
2	Histones (Histone)IBA 01/2024 - 02/2020
2	Edetic Acid (EDTA)FDA Link 01/2024 - 07/2022
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2022 - 01/2014
2	LipopolysaccharidesIBA 07/2022 - 02/2020
2	Caspase 3 (Caspase-3)IBA 04/2022 - 02/2019
2	Neurofibromin 2 (Merlin)IBA 11/2021 - 01/2020
2	Tryptophan (L-Tryptophan)FDA Link 05/2021 - 01/2020
2	Fluorescent Dyes (Fluorescent Probes)IBA 12/2020 - 02/2019
2	Hypoxia-Inducible Factor 1IBA 11/2020 - 11/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 05/2018
2	VaccinesIBA 02/2020 - 01/2019
2	CateninsIBA 01/2020 - 01/2016
2	gamma-Aminobutyric Acid (GABA)IBA 12/2019 - 02/2016
2	FluoridesIBA 12/2019 - 02/2016
2	Aminobutyrates (Aminobutyric Acid)IBA 12/2019 - 02/2016
2	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 10/2019
2	Antiviral Agents (Antivirals)IBA 02/2019 - 07/2016
2	embelinIBA 09/2018 - 05/2018
2	X-Linked Inhibitor of Apoptosis ProteinIBA 09/2018 - 05/2018
2	Potassium Channels (Potassium Channel)IBA 06/2014 - 08/2013

Therapy/Procedure

15	Therapeutics 05/2024 - 10/2007
5	Lasers (Laser) 01/2024 - 11/2008
4	Drug Therapy (Chemotherapy) 04/2023 - 01/2014
2	Ligation 01/2024 - 05/2008
2	Sutures (Suture) 06/2023 - 06/2016
2	Oral Administration 04/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2014 - 06/2010